ARCPOINT INC (ARC.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:ARC - CA03966D1078 - Common Stock
ARC.CA Key Statistics, Chart & Performance
The current stock price of ARC.CA is 0.015 CAD. In the past month the price decreased by -62.5%. In the past year, price decreased by -90%.
ARC.CA Latest News, Press Relases and Analysis
ARC.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL-DB.CA | WELL HEALTH TECHNOLOGIES | N/A | 25.64B | ||
| DNTL.CA | DENTALCORP HOLDINGS LTD | 20.57 | 2.08B | ||
| WELL.CA | WELL HEALTH TECHNOLOGIES COR | N/A | 992.87M | ||
| AIDX.CA | HEALWELL AI INC | N/A | 269.64M | ||
| NLH.CA | NOVA LEAP HEALTH CORP | N/A | 25.76M | ||
| NPTH.CA | NEUPATH HEALTH INC | N/A | 23.62M | ||
| PHA.CA | PREMIER HEALTH OF AMERICA IN | N/A | 1.11M |
Related stock screener links
About ARC.CA
Company Profile
ARCpoint, Inc. engages in the provision of drug testing, alcohol screening, DNA, and clinical lab testing. The company is headquartered in Greenville, South Carolina. The firm provides a United States-based franchise system offering drug testing, alcohol screening, deoxyribonucleic acid (DNA) and clinical lab testing, corporate wellness programs and employment and background screening and other services. Its segments include ARCpoint Franchise, AFG Services, and Other. The ARCpoint Franchise segment includes franchise labs. The AFG Services segment consists primarily of clinical testing and software services that support its franchise systems. This segment also includes diagnostic testing kits sold to franchisees as well as other direct business to business customers. The Other segment consists of corporately held ARCpoint Lab franchises. The firm sells franchises to individuals throughout the United States and provides support in the form of marketing, technology, and training to new franchisees. The company develops corporate-owned labs committed to providing solutions for customers, businesses, and physicians.
Company Info
ARCPOINT INC
101 North Main St., Suite 301
Greenville SOUTH CAROLINA V6E 3T5 US
CEO: Robert B. Naso
Employees: 0
Phone: 16048897827
ARCPOINT INC / ARC.CA FAQ
Can you describe the business of ARCPOINT INC?
ARCpoint, Inc. engages in the provision of drug testing, alcohol screening, DNA, and clinical lab testing. The company is headquartered in Greenville, South Carolina. The firm provides a United States-based franchise system offering drug testing, alcohol screening, deoxyribonucleic acid (DNA) and clinical lab testing, corporate wellness programs and employment and background screening and other services. Its segments include ARCpoint Franchise, AFG Services, and Other. The ARCpoint Franchise segment includes franchise labs. The AFG Services segment consists primarily of clinical testing and software services that support its franchise systems. This segment also includes diagnostic testing kits sold to franchisees as well as other direct business to business customers. The Other segment consists of corporately held ARCpoint Lab franchises. The firm sells franchises to individuals throughout the United States and provides support in the form of marketing, technology, and training to new franchisees. The company develops corporate-owned labs committed to providing solutions for customers, businesses, and physicians.
What is the stock price of ARCPOINT INC today?
The current stock price of ARC.CA is 0.015 CAD.
Does ARC stock pay dividends?
ARC.CA does not pay a dividend.
How is the ChartMill rating for ARCPOINT INC?
ARC.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the employee count for ARC stock?
ARCPOINT INC (ARC.CA) currently has 0 employees.
ARC.CA Technical Analysis
ARC.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ARC.CA. Both the profitability and financial health of ARC.CA have multiple concerns.
ARC.CA Financial Highlights
Over the last trailing twelve months ARC.CA reported a non-GAAP Earnings per Share(EPS) of 0.03. The EPS increased by 112.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 53.94% | ||
| ROA | 69.77% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |